| Target Price | CHF192.27 |
| Price | CHF172.05 |
| Potential | 11.75% |
| Number of Estimates | 30 |
| 30 Analysts have issued a price target Richemont 2027 . The average Richemont target price is CHF192.27. This is 11.75% higher than the current stock price. The highest price target is CHF231.00 34.26% , the lowest is CHF133.32 22.51% . | |
| A rating was issued by 30 analysts: 21 Analysts recommend Richemont to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Richemont stock has an average upside potential 2027 of 11.75% . Most analysts recommend the Richemont stock at Purchase. |
| Mar '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion CHF | 19.87 | 20.87 |
| 3.80% | 4.99% | |
| EBITDA Margin | 21.23% | 27.00% |
| 10.50% | 27.18% | |
| Net Margin | 12.86% | 16.41% |
| 12.21% | 27.65% |
26 Analysts have issued a sales forecast Richemont 2026 . The average Richemont sales estimate is CHF20.9b . This is 2.40% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF23.4b 14.62% , the lowest is CHF19.4b 4.74% .
This results in the following potential growth metrics:
| 2025 | CHF19.9b | 3.80% |
|---|---|---|
| 2026 | CHF20.9b | 4.99% |
| 2027 | CHF22.3b | 6.93% |
| 2028 | CHF23.9b | 7.22% |
| 2029 | CHF25.3b | 5.62% |
| 2030 | CHF27.2b | 7.50% |
| 2031 | CHF29.1b | 7.02% |
| 2032 | CHF31.0b | 6.66% |
28 Richemont Analysts have issued a net profit forecast 2026. The average Richemont net profit estimate is CHF3.4b . This is 10.18% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF4.2b 8.88% , the lowest is CHF3.1b 18.75% .
This results in the following potential growth metrics and future Net Margins:
| 2025 | CHF2.6b | 16.47% |
|---|---|---|
| 2026 | CHF3.4b | 34.06% |
| 2027 | CHF3.9b | 14.50% |
| 2028 | CHF4.4b | 12.74% |
| 2029 | CHF4.9b | 10.31% |
| 2030 | CHF5.3b | 8.90% |
| 2031 | CHF5.7b | 6.71% |
| 2032 | CHF6.0b | 5.80% |
| 2025 | 12.86% | 12.21% |
|---|---|---|
| 2026 | 16.41% | 27.65% |
| 2027 | 17.58% | 7.13% |
| 2028 | 18.48% | 5.12% |
| 2029 | 19.30% | 4.44% |
| 2030 | 19.56% | 1.35% |
| 2031 | 19.50% | 0.31% |
| 2032 | 19.34% | 0.82% |
| Mar '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 4.34 | 5.83 |
| 14.81% | 34.33% | |
| P/E | 29.53 | |
| EV/Sales | 4.76 |
28 Analysts have issued a Richemont forecast for earnings per share. The average Richemont EPS is CHF5.83 . This is 9.89% lower than earnings per share in the financial year 2025. The highest EPS forecast is CHF7.06 9.12% , the lowest is CHF5.27 18.55% .
This results in the following potential growth metrics and future valuations:
| 2025 | CHF4.34 | 14.81% |
|---|---|---|
| 2026 | CHF5.83 | 34.33% |
| 2027 | CHF6.67 | 14.41% |
| 2028 | CHF7.52 | 12.74% |
| 2029 | CHF8.30 | 10.37% |
| 2030 | CHF9.03 | 8.80% |
| 2031 | CHF9.64 | 6.76% |
| 2032 | CHF10.20 | 5.81% |
| Current | 26.59 | 59.92% |
|---|---|---|
| 2026 | 29.53 | 11.05% |
| 2027 | 25.79 | 12.67% |
| 2028 | 22.88 | 11.28% |
| 2029 | 20.74 | 9.35% |
| 2030 | 19.05 | 8.15% |
| 2031 | 17.85 | 6.30% |
| 2032 | 16.87 | 5.49% |
Based on analysts' sales estimates for 2026, the Richemont stock is valued at an EV/Sales of 4.76 and an P/S ratio of 4.84 .
This results in the following potential growth metrics and future valuations:
| Current | 4.87 | 29.52% |
|---|---|---|
| 2026 | 4.76 | 2.35% |
| 2027 | 4.45 | 6.48% |
| 2028 | 4.15 | 6.73% |
| 2029 | 3.93 | 5.32% |
| 2030 | 3.65 | 6.98% |
| 2031 | 3.41 | 6.56% |
| 2032 | 3.20 | 6.25% |
| Current | 4.95 | 28.82% |
|---|---|---|
| 2026 | 4.84 | 2.34% |
| 2027 | 4.53 | 6.48% |
| 2028 | 4.22 | 6.73% |
| 2029 | 4.00 | 5.32% |
| 2030 | 3.72 | 6.97% |
| 2031 | 3.47 | 6.56% |
| 2032 | 3.26 | 6.25% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Hold
➜
Hold
|
Unchanged | Dec 15 2025 |
| ROTHSCHILD & CO REDBURN |
Neutral
➜
Neutral
|
Unchanged | Dec 09 2025 |
| ANCHOR STOCKBROKERS |
Hold
➜
Hold
|
Unchanged | Nov 26 2025 |
| HSBC GLOBAL INVESTMENT RESEARCH |
Hold
➜
Buy
|
Upgrade | Nov 25 2025 |
| TD COWEN |
Buy
➜
Buy
|
Unchanged | Nov 21 2025 |
| BANCO SANTANDER |
Outperform
➜
Outperform
|
Unchanged | Nov 19 2025 |
| ODDO BHF |
Buy
➜
Buy
|
Unchanged | Nov 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
BERENBERG:
Hold
➜
Hold
|
Dec 15 2025 |
|
Unchanged
ROTHSCHILD & CO REDBURN:
Neutral
➜
Neutral
|
Dec 09 2025 |
|
Unchanged
ANCHOR STOCKBROKERS:
Hold
➜
Hold
|
Nov 26 2025 |
|
Upgrade
HSBC GLOBAL INVESTMENT RESEARCH:
Hold
➜
Buy
|
Nov 25 2025 |
|
Unchanged
TD COWEN:
Buy
➜
Buy
|
Nov 21 2025 |
|
Unchanged
BANCO SANTANDER:
Outperform
➜
Outperform
|
Nov 19 2025 |
|
Unchanged
ODDO BHF:
Buy
➜
Buy
|
Nov 17 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


